Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles M Perou

Showing results (231-240 of 447) with videos related to

Pageof 45
Sort By:
Plos One|May 8, 2013
Pharmacokinetics and efficacy of PEGylated liposomal doxorubicin in an intracranial model of breast cancerCarey K Anders, Barbara Adamo, Olga Karginova, et al.
Genome Biology|November 14, 2013
Transcriptomic classification of genetically engineered mouse models of breast cancer identifies human subtype counterpartsAdam D Pfefferle, Jason I Herschkowitz, Jerry Usary, et al.
Nucleic Acids Research|August 31, 2010
MapSplice: accurate mapping of RNA-seq reads for splice junction discoveryKai Wang, Darshan Singh, Zheng Zeng, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 4, 2010
Relationship between plasma estradiol levels and estrogen-responsive gene expression in estrogen receptor-positive breast cancer in postmenopausal womenAnita K Dunbier, Helen Anderson, Zara Ghazoui, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 4, 2017
PAM50 Provides Prognostic Information When Applied to the Lymph Node Metastases of Advanced Breast Cancer PatientsNicholas P Tobin, Arian Lundberg, Linda S Lindström, et al.
Cancer Cell|December 11, 2007
ETV6-NTRK3 fusion oncogene initiates breast cancer from committed mammary progenitors via activation of AP1 complexZhe Li, Cristina E Tognon, Frank J Godinho, et al.
International Journal of Cancer|August 9, 2007
Common genetic variation in TP53 and its flanking genes, WDR79 and ATP1B2, and susceptibility to breast cancerMontserrat Garcia-Closas, Vessela Kristensen, Anita Langerød, et al.
Cancer Prevention Research (Philadelphia, Pa.)|April 7, 2018
PAM50 and Risk of Recurrence Scores for Interval Breast CancersSamantha Puvanesarajah, Sarah J Nyante, Cherie M Kuzmiak, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 15, 2010
Allele-specific copy number analysis of tumorsPeter Van Loo, Silje H Nordgard, Ole Christian Lingjærde, et al.
The American Journal of Pathology|December 6, 2002
Expression of cytokeratins 17 and 5 identifies a group of breast carcinomas with poor clinical outcomeMatt van de Rijn, Charles M Perou, Rob Tibshirani, et al.
Pageof 45

Showing results (231-240 of 447) with videos related to

Sort By:
Pageof 45
Plos One|May 8, 2013
Pharmacokinetics and efficacy of PEGylated liposomal doxorubicin in an intracranial model of breast cancerCarey K Anders, Barbara Adamo, Olga Karginova, et al.
Genome Biology|November 14, 2013
Transcriptomic classification of genetically engineered mouse models of breast cancer identifies human subtype counterpartsAdam D Pfefferle, Jason I Herschkowitz, Jerry Usary, et al.
Nucleic Acids Research|August 31, 2010
MapSplice: accurate mapping of RNA-seq reads for splice junction discoveryKai Wang, Darshan Singh, Zheng Zeng, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 4, 2010
Relationship between plasma estradiol levels and estrogen-responsive gene expression in estrogen receptor-positive breast cancer in postmenopausal womenAnita K Dunbier, Helen Anderson, Zara Ghazoui, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 4, 2017
PAM50 Provides Prognostic Information When Applied to the Lymph Node Metastases of Advanced Breast Cancer PatientsNicholas P Tobin, Arian Lundberg, Linda S Lindström, et al.
Cancer Cell|December 11, 2007
ETV6-NTRK3 fusion oncogene initiates breast cancer from committed mammary progenitors via activation of AP1 complexZhe Li, Cristina E Tognon, Frank J Godinho, et al.
International Journal of Cancer|August 9, 2007
Common genetic variation in TP53 and its flanking genes, WDR79 and ATP1B2, and susceptibility to breast cancerMontserrat Garcia-Closas, Vessela Kristensen, Anita Langerød, et al.
Cancer Prevention Research (Philadelphia, Pa.)|April 7, 2018
PAM50 and Risk of Recurrence Scores for Interval Breast CancersSamantha Puvanesarajah, Sarah J Nyante, Cherie M Kuzmiak, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 15, 2010
Allele-specific copy number analysis of tumorsPeter Van Loo, Silje H Nordgard, Ole Christian Lingjærde, et al.
The American Journal of Pathology|December 6, 2002
Expression of cytokeratins 17 and 5 identifies a group of breast carcinomas with poor clinical outcomeMatt van de Rijn, Charles M Perou, Rob Tibshirani, et al.
Pageof 45